Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.090
-0.010 (-0.32%)
Sep 25, 2026, 9:28 AM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 34.53 million as of September 24, 2026. Its market cap has decreased by -13.41% in one year.
Market Cap
34.53M
Enterprise Value
34.42M
Revenue
1.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.09
ChartMarket Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 34.53M, a decrease of -79.93%. That is a compound annual growth rate of -8.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 34.53M | 19.23% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 646.65M |
| Captor Therapeutics Spolka Akcyjna | 454.27M |
| Bioceltix | 416.58M |
| Ryvu Therapeutics | 367.61M |
| BIOTON | 302.67M |
| Synthaverse | 217.46M |
| Molecure | 159.67M |
| Mabion | 126.07M |